Ben Wan

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 69 citations · Full text

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +7

Anti-osteosarcoma effect of hydroxyapatite nanoparticles both <i>in vitro</i> and <i>in vivo</i> by downregulating the FAK/PI3K/Akt signaling pathway

Renxian Wang, Weifeng Liu, Qian Wang et al. · Biomaterials Science · 2020 · 38 citations

MFAE: Masked Frequency Autoencoders for Domain Generalization Face Anti-Spoofing

Tianyi Zheng, Bo Li, Shuang Wu et al. · IEEE Transactions on Information Forensics and Security · 2024 · 27 citations

Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial

Xiaojian Qin, Dongmei Ji, Weijie Gu et al. · BMC Medicine · 2022 · 23 citations · Full text